News Articles

Monday Oct 02, 2023 - 9:00 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Finalizes Rebrand to Reflect New Strategic Direction, Diversification

Scinai Immunotherapeutics, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, recently finalized a major rebrand, changing its corporate name from BiondVax Pharmaceuticals The rebrand is part of a series of steps to better reflect the company’s new direction and new developments aimed at new scientific breakthroughs Amir Reichman took over as CEO in March 2021 and together with the Board of…

Friday Sep 29, 2023 - 11:15 am

PaxMedica Inc. (NASDAQ: PXMD) Releases Compelling Video: Progress Report on ASD and Hope for the Future

Autism Spectrum Disorder (“ASD”) has seen a staggering fourfold increase in the United States over the past two decades PaxMedica proudly stands as the sole publicly traded U.S. company singularly dedicated to addressing the challenges posed by Autism Our pioneering lead product, PAX-101, has shown significant promise in alleviating core Autism symptoms during early trials In 2024, we're poised to submit a New Drug Application…

Friday Sep 29, 2023 - 10:30 am

GEMXX Corp. (GEMZ) Plans 300% YoY Expansion in Gemstone and Jewelry Production to Meet Growing Demand

GEMXX is a mine-to-market enterprise that specializes in the production and distribution of gemstones, like Ammolite, and jewelry on a global scale Ammolite is a rare gemstone that exhibits a unique iridescence and is only found in southern Alberta, Canada The company recently announced that demand for its Ammolite in jewelry designs by Kenneth Bradley is growing exponentially GEMXX plans to expand gemstone and jewelry…

Friday Sep 29, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Advancing its DehydraTECH(TM) Technology, Having Demonstrated its Potential Across Multiple Areas of Application

Lexaria’s patented DehydraTECH(TM)-processed CBD has shown its ability to lower blood pressure in patients over multiple weeks This technology has also shown positive impacts in obese diabetic-conditioned animals from its DIAB-A22-1 pre-clinical study The NIC-H22-1 human nicotine study also demonstrated a statistically significant difference to achieve maximum blood saturation These results have demonstrated DehydraTECH’s potential while propping it to take advantage of vastly untapped markets…

Friday Sep 29, 2023 - 9:00 am

Unveiling the Neuroprotective Power of CNMAu8 A Promising Breakthrough in Neurodegenerative Disease Treatment

by Elaine Mendonça On September 28, 2023, Clene Inc. (NASDAQ: CLNN) made an exciting announcement regarding their groundbreaking research on the investigational drug CNM-Au8. In a scientific paper published in the esteemed journal Small, Clene Inc. revealed the catalytic mechanism of action behind the therapeutic properties of CNM-Au8. The study showcased the remarkable neuroprotective abilities of CNM-Au8, attributing its success to its unique catalytic activity. When exposed to…

Thursday Sep 28, 2023 - 10:30 am

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Strategically Positioned for Record Growth Amidst Canada’s Push for Sustainability in the Oil and Gas Industry

As one of the oil and gas leaders, Canada is the third-largest holder of proven oil reserves in the world; the country’s oil and gas sector is not only big but also green, positioning Canada as an energy powerhouse with an eye on a greener future The sector reported output growth while slashing emissions, standing as a testament that achieving both growth and environmental sustainability…

Thursday Sep 28, 2023 - 9:45 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) Presents Achievements, Goals at H.C. Wainwright 25th Annual Global Investment Conference in New York City

RVL Pharmaceuticals CEO Brian Markison participated in a fireside chat and hosted one-on-one investor meetings during the conference The company's primary focus is the commercialization of UPNEEQ(R), which is available by prescription for treating acquired blepharoptosis or low-lying eyelids in adults The global medical aesthetics market was estimated at $13.9 billion in 2022 and is expected to reach $23.4 billion by 2027, growing at a…

Thursday Sep 28, 2023 - 9:00 am

Clene Inc. (NASDAQ: CLNN) Is ‘One to Watch’

In June 2023, The Lancet’s eClinicalMedicine journal published combined detailed analyses of Clene’s Phase 2 RESCUE-ALS study and its open-label extension trial In June 2023, Clene announced the closing of a $40 million underwritten public offering with potentially up to an additional $130 million from future warrant exercises As of January 2023, Clene had more than 150 issued patents worldwide and approximately 20 patents pending worldwide on…

Wednesday Sep 27, 2023 - 9:45 am

Longeveron Inc. (NASDAQ: LGVN) Eyeing Global HLHS, in addition to Alzheimer’s Disease, and Aging-Related Frailty Treatment Markets with Lomecel-B(TM), its Lead Investigational Product

Longeveron’s study ELPIS I demonstrated 100% survival and heart transplant-free for up to 5 years of age All ten patients enrolled in the study were monitored for at least 3.5 years after treatment with Lomecel-B(TM), the company’s lead investigational product Longeveron’s study results show Lomecel-B(TM)’s potential, not just for the potential treatment of HLHS but also for Alzheimer’s disease and Aging-related Frailty Longeveron (NASDAQ: LGVN),…

Wednesday Sep 27, 2023 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Showcases Quantum’s Real-World Value Through Customer Success Stories

D-Wave is the world’s first commercial supplier of quantum computing solutions D-Wave’s customers have built quantum and quantum-hybrid applications in areas such as resource scheduling, mobility, logistics, drug discovery, portfolio optimization, manufacturing processes, and more Using D-Wave’s annealing quantum computing solutions, SavantX was able to increase deliveries per crane per day by 60% at Pier 300 at the Port of Los Angeles, one of the…

Tuesday Sep 26, 2023 - 11:15 am

Dawson James Small Cap Growth Conference: Exploring a Changing World of Investment Opportunities

Capital marketers, insurance and wealth management experts, investment bankers, individual investors, and research analysts, are invited to attend the Dawson James Small Cap Growth Conference to be held in Wyndham Grand Harborside Jupiter, Jupiter, FL, October 12, 2023. The distinguished conference serves as a hallmark in the financial world, featuring important management experts slated to share cutting-edge innovations, strategies, and growth opportunities. The highly anticipated…

Tuesday Sep 26, 2023 - 10:30 am

Social Media Strategies Summit Higher Education: Offering The Latest And Best Practices In Social Media Marketing From Today’s Leading Colleges And Universities

Educators, marketers, social media professionals, thought leaders, and research analysts, are invited to attend the Social Media Strategies Summit Higher Education to be held virtually on October 23-24, 2023, with an optional workshop October 25. The eminent summit aims to reshape the academic landscape with transformative insights, advanced strategies, and unmatched networking opportunities. The summit is committed to revealing the secrets of social media success…

Tuesday Sep 26, 2023 - 9:45 am

Amid REE Market Supply Interruptions, Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Presses Forward With Commercial Processing Plant Plans

Ucore Rare Metals Inc. is moving forward with a rare earth element (“REE”) processing facility in Louisiana that will help to establish an American base for the REE supply chain The REE supply chain is currently almost exclusively controlled by the People’s Republic of China thanks to China’s responsibility for 36.7 percent of the world’s REE reserves, 63 percent of REE mining capacity and more…

Tuesday Sep 26, 2023 - 9:00 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) Looking to Capitalize on UPNEEQ’s Significant Potential

UPNEEQ(R) is the first FDA-approved non-surgical treatment option for acquired blepharoptosis (ptosis), or low-lying eyelid Clinical studies have shown an average one-millimeter lift of the upper eyelid, with results in as little as five minutes post-dose UPNEEQ(R) is available through RVL Pharmaceuticals’ dedicated e-commerce platform, Elevate, which supports subscription ordering by HCPs and RVL Pharmacy patients RVL is poised to be an integral player in…

Monday Sep 25, 2023 - 11:15 am

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Commences Diamond Drilling with Third Drill Hole at PCH Project in Brazil

The global rare earth elements market is expected to grow from 167.99 million tons in 2023, and to 206.25 million tons by 2028 – growing at a CAGR of 4.19% Since starting the project, Appia has commenced diamond drilling in addition to its current reverse circulation and auger drilling campaigns Specimens from the drilling efforts will be submitted to SGS Geosol laboratory, with assays expected…

Monday Sep 25, 2023 - 10:30 am

Trial Enrollment Growth Supports Plans of CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Complete Enrollment for Important Brain Cancer Drug Study

CNS Pharmaceuticals is conducting a global clinical trial to evaluate its flagship drug candidate for treating glioblastoma, a deadly brain cancer CNS has enrolled 200 of its planned 243 patients for its clinical trial roster, and anticipates filling out the remainder of patients by year’s end The company is also preparing the interim study analysis for release by year’s end, now that more than 50…

Monday Sep 25, 2023 - 9:45 am

Electronic Servitor Publication Network Inc. (XESP) Helps Businesses Compete and Win Through The Increasingly Recognized Necessity of Marketing Automation

XESP, through its Digital Engagement Engine(TM), is making automation, powerful data management, and an advanced workflow, more accessible to B2B companies The company allows businesses to offer buyers meaningful and empowering experiences, making them feel appreciated and understood, and moving them to action XESP understands businesses’ concerns, especially regarding the cost of automation, and continues to refine its products, integrating new features and addressing emerging…

Monday Sep 25, 2023 - 9:00 am

GolfLync Inc.’s Pebble Beach Sweepstakes Ends October 1, 2023: This is Your Last Chance to Win a Dream Golf Trip to Pebble Beach Resorts

GolfLync, the leading social networking platform for golfers, is thrilled to remind you about the GolfLync Pebble Beach Sweepstakes, your golden opportunity to win the golf trip of a lifetime to the iconic Pebble Beach Resorts, acclaimed as the No. 1 Golf Resort in America. Pebble Beach Resorts, nestled on California's breathtaking Monterey Peninsula, offers an unparalleled golfing experience. With its three Top 50 public…

Friday Sep 22, 2023 - 9:45 am

ESG Forum (a Sustain SoCal Event) – Moving Toward a Sustainable Future

Investors, policymakers, academicians, technologists, decision-makers, and business owners are invited to attend the ESG Forum (a Sustain SoCal event) to be held at the Cove, UCI Beall Applied Innovation, September 26, 2023. The highly anticipated event offers a unique platform for improving sustainable business practices. Committed to fostering environmental stewardship, the professionals will delve into the key aspects of Environmental, Social, and Governance (“ESG”) practices.…

Friday Sep 22, 2023 - 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Building Domestic REE Supply Chain Alternatives for China-dependent Market

Ucore Rare Metals Inc. is focused on establishing its proprietary solvent-based solution as a commercially advantageous and important alternative to standard rare earth (“REE”) processing U.S. Trade Representative Katherine Tai recently noted in a media interview that the REE supply chain is dependent on China for production and, to a greater degree, processing once ore has been removed from the ground Ucore’s development of its…

Thursday Sep 21, 2023 - 11:15 am

Charting the Future of Biopharma and Medical Devices: DGE’s 2nd Chief Commercial Officer Summit Convenes Industry Leaders in Philadelphia

DGE invites biotech, pharmaceutical and medical device leaders to attend the 2nd Chief Commercial Officer Summit to be held at The Bellevue Hotel, Philadelphia, PA, October 4-5, 2023. The much-awaited summit aims to chart the remarkable future of the biotech, pharmaceutical and medical device industries. The landmark event will feature a gathering of thought leaders and visionaries dedicated to driving commercial growth in the industry.…

Thursday Sep 21, 2023 - 10:30 am

New Orleans Investment Conference: Shaping the Future of Investment Innovation

Investors, policymakers, enthusiasts, technologists, decision-makers, and business owners are invited to attend the New Orleans Investment Conference to be held in New Orleans, Louisiana, November 1-4, 2023. The 2023 edition of this iconic event is committed to paving the way to real investment insights and financial wisdom in a fast-changing economic landscape. Having a rich history of successful investment symposiums, the New Orleans Investment Conference…

Thursday Sep 21, 2023 - 9:45 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Is ‘One to Watch’

In September 2023, Sekur Private Data announced that it had signed a distribution agreement with VYRE Network, a leading news-based streaming channel and website, for the Sekur suite of solutions The company has no debt and no convertible equity Sekur Private Data in June 2023 announced that it is on track to launch Sekur Enterprise Solutions, its new product for SMBs, large enterprises and government…

Thursday Sep 21, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming Investigational New Drug Application Submission

Lexaria’s IND application builds on five previous human clinical studies showing zero serious adverse effects and evidencing a reduction in resting blood pressure in test subjects DehydraTECH(TM)-CBD has the potential to have pronounced clinical benefits relative to the available anti-hypertensive therapeutics on the market today Work mostly under Lexaria’s control was completed earlier this year, including the batch manufacturing of DehydraTECH-CBD and placebo materials necessary…

Wednesday Sep 20, 2023 - 1:30 pm

Innovating Medical Devices Design: DGE’s 4th Human Factors Engineering & Usability Studies Congress Convenes in Philadelphia

DGE invites medical device design, safety, and compliance professionals to attend the 4th Human Factors Engineering & Usability Studies Congress to be held at The Bellevue Hotel, Philadelphia, PA, October 4-5, 2023. The distinguished event serves as a decisive knowledge-sharing platform focused on the complicated procedural, technical, and collaborative challenges that usability teams face. The 4th Human Factors Engineering & Usability Studies Congress focuses on…

Wednesday Sep 20, 2023 - 12:45 pm

EV Charging Infrastructure Summit: A Step Towards Sustainable Future

Investors, industry leaders, decision-makers, and business owners, are invited to attend the GSMI “EV Charging Infrastructure Summit”, September 27-28, 2023. This virtual event will explore sustainable energy solutions while driving advancement and positive change within the industry. Featuring interactive panel discussions and insightful keynote presentations, the EV Charging Infrastructure Summit offers an important platform for innovation and collaboration. As the electric vehicle trend is gaining…

Wednesday Sep 20, 2023 - 11:15 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources

California-based cancer fighter Renovaro BioSciences is turning the power of its immune system-promoting technology to the fight against pancreatic cancer and other illnesses that tend to leave patients with a short life expectancy once they are diagnosed Renovaro recently announced a binding, exclusive letter of intent (“LOI”) to add GEDI Cube’s artificial intelligence (“AI”) data mining technology to its fight against such cancers GEDI Cube…

Wednesday Sep 20, 2023 - 10:30 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Exploration at Deer Horn Provides Key Data for September Drill Program

CEO notes that prospecting, mapping and sampling have provided an extensive base of information to support drilling and IP survey Last month’s property-wide mapping and sampling program confirmed a structural connection between two key sections of the property This month’s drilling program will test the extent of the mineralization and study how the systems at Deer Horn and Pond are related First Tellurium (CSE: FTEL)…

Wednesday Sep 20, 2023 - 9:45 am

Electronic Servitor Publication Network Inc. (XESP) Provides Unique Digital Engagement Offering in Revenue-Driven Customer Engagement Solutions Market

The global customer engagement solutions market is growing exponentially, driven by reduced churn rates and a preference for e-commerce platforms Larger companies in the industry, like Service Now, Salesforce, and OpenAI, have seen significant revenue and market caps based on their marketing offerings Electronic Servitor Publication Network’s Digital Engagement Engine(TM) offers a unique multi-channel digital engagement experience that allows for targeting the narrowest of niches…

Wednesday Sep 20, 2023 - 9:00 am

Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology

U.S.-based generic drug developer SOHM is working to build its product pipeline through registration for distribution in several states and the planned establishment of its own product manufacturing plant in Southern California SOHM is also focused on developing a regenerative medicine portfolio, having issued an LOI recently in its bid to acquire the gene editing technology ABBIE from CGA Intellectual Holdings Inc. ABBIE is a…

Tuesday Sep 19, 2023 - 9:45 am

RJD Green Inc. (RJDG) Subsidiary, Silex Holdings Undertakes Efficiency Drive, Implements StoneAPP within Operations

Silex Holdings, a subsidiary of holding company RJD Green, revealed that they would be implementing the use of software platform, StoneAPP across its business The software is expected to assist the company in both, reducing overall inventory costs whilst generating other ancillary savings expected to total as much as $300,000 per annum Silex has been a recent beneficiary of the U.S. home renovation boom, seeing…

Tuesday Sep 19, 2023 - 9:00 am

SenesTech Inc. (NASDAQ: SNES) Is ‘One to Watch’

SenesTech announced in August 2023 the closing of an exercise of warrants to purchase nearly 3 million shares of its common stock, with proceeds earmarked for existing product launches The company in July 2023 began delivery of the Isolate Bait System(TM), its newest delivery system for ContraPest(R) SenesTech reported Q2 2023 revenues of $305,000, compared to $277,000 in Q2 2022 The company reported gross profit…

Monday Sep 18, 2023 - 10:30 am

420 Expo 2023: Celebrating the Cannabis Culture

Cannabis enthusiasts, investors, decision-makers, and business owners, are invited to attend the 420 Expo 2023 to be held in New Jersey Expo Center, Edison, NJ from September 29 – October 1, 2023. The electrifying event is set to blaze the ever-evolving cannabis landscape, including medical experts discussing the therapeutic potential of cannabis and professionals sharing their success stories. 420 Expo 2023 is a one-of-a-kind gathering…

Monday Sep 18, 2023 - 9:45 am

Near Intelligence Inc. (NASDAQ: NIR) Is ‘One to Watch’

For Q2 2023 ended June 30, Near reported revenue of $17.7 million, up 19% over Q2 2022 For the same 2023 period, the company reported GAAP gross profit of $12.1 million Near’s GAAP gross margin for Q2 2023 was 68% The company’s Q3 2023 guidance forecasts total revenue in the range of $18 million to $20 million Near holds 10 patents globally and has a…

Monday Sep 18, 2023 - 9:00 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Focused on Finding, Delivering Tellerium, the ‘Bright Future of Solar Energy’

USGS reports that tellurium’s primary use is for manufacturing films essential to photovoltaic solar cells Most tellurium is indirectly mined because it is a byproduct of milled copper, iron and other base-metal-rich ore bodies First Tellurium is exploring, developing tellurium projects, confident that demand for tellurium will increase Calling tellurium “the bright future of solar energy,” the U.S. Geological Survey (“USGS”) has prepared a report…

Friday Sep 15, 2023 - 9:45 am

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announce New Mining Updates; Confirm Timeline for NI-43101 Compliant MRE Report Publication

Eloro Resources recently provided an update on the company’s ongoing exploratory drill work Recent findings revealed a number of holes with well-mineralized intersections, suggesting both – robust mineralization trends as well as an ever-widening prospective target area Global tin demand is set to grow by nearly a third over the next 8 years, however, the supply growth picture is looking increasingly tenuous Eloro Resources looks…

Friday Sep 15, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) is On Track for IND Application with the FDA for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria’s IND application for its U.S. Phase 1b Hypertension Clinical Study, HYPER-H23-1, remains on track despite setbacks Work mostly under Lexaria’s control was completed earlier this year, while work that is outside its control remains delayed Regardless, Lexaria continues to make progress, even as it looks to take advantage of the growing global cardiovascular drugs market, which is projected to post a CAGR of 3.1%…

Thursday Sep 14, 2023 - 9:45 am

Longeveron Inc. (NASDAQ: LGVN) to Discuss Its Cellular Therapy Programs, Clinical Trial Progress at the 25th Annual H.C. Wainwright Global Investment Conference

Longeveron management will present at the 25th Annual H.C. Wainwright Global Investment Conference scheduled for September 11-13, 2023, in New York Wa’el Hashad, the company’s CEO, will discuss Longeveron’s cellular therapy programs in a pre-recorded presentation. Both he and Lisa Locklear, EVP & Chief Financial Officer, will be at the conference to discuss the company’s investment strategies and clinical trial progress The company aims to…

Thursday Sep 14, 2023 - 9:00 am

Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development

U.S.-based generic drug developer SOHM recently announced the addition of two leading officers — Dr. David Aguilar (Ph.D) as Chief Operating Officer and Dr. Krishna Bhat (MD, Ph.D, FACC) as Chief Medical Advisor The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics,…

Wednesday Sep 13, 2023 - 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’

PaxMedica recently announced positive top line results from its PAX-101 Phase 3 African Sleeping Sickness Study, paving the way for an expected New Drug Application filing in 2024 The company granted exclusive pharmacy distribution for PAX-101 to Vox Nova LLC, the first purpose-built limited distribution specialty pharmacy benefit manager for people with ASD PaxMedica submitted PAX-101 Clinical Trial Request to the South African Health Products…

Articles

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions